The Daily Pennsylvanian is a student-run nonprofit.

Please support us by disabling your ad blocker on our site.

A team of researchers at Penn Medicine’s Scheie Eye Institute developed an experimental RNA therapy that reversed blindness in a patient with a genetic disorder.

All comments eligible for publication in Daily Pennsylvanian, Inc. publications.